Mepolizumab-Related Blood Eosinophil Decreases Are Associated with Clinical Remission in Severe Asthmatic Patients: A Real-World Study
<b>Background</b>: Mepolizumab is an effective treatment for severe eosinophilic asthma, leading to a depletion of blood eosinophil levels, the clinical relevance of which remains unclear. <b>Objective</b>: The aim of this study was to assess the relationship between mepolizumab-induced blood eosino...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2025-07-01
|
| Seria: | Antibodies |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/2073-4468/14/3/61 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|